Celularity Inc. Total Contract Liability
Celularity Inc. (CELU) had Total Contract Liability of $8.05 million as of 2025-12-31, per its 10-K filed 2026-04-30.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2026-04-30
- 2025-12-31: Contract with Customer, Liability $8.05M.
- 2025-09-30: Contract with Customer, Liability $8.35M.
- 2025-06-30: Contract with Customer, Liability $6.37M.
- 2025-03-31: Contract with Customer, Liability $6.28M.
| Period end | Contract with Customer, Liability |
|---|---|
| 2025-12-31 | $8.05M 10-K · filed 2026-04-30 |
| 2025-09-30 | $8.35M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $6.37M 10-Q · filed 2025-08-29 |
| 2025-03-31 | $6.28M 10-Q · filed 2025-08-29 |
| 2024-12-31 | $6.25M 10-K · filed 2026-04-30 |
| 2024-09-30 | $6.33M 10-Q · filed 2024-12-06 |
| 2024-06-30 | $6.23M 10-Q · filed 2024-11-07 |
| 2024-03-31 | $6.07M 10-Q · filed 2024-10-16 |
| 2023-12-31 | $6.02M 10-K · filed 2026-04-30 |
| 2023-09-30 | $5.56M 10-Q · filed 2024-12-06 |
| 2023-06-30 | $4.67M 10-Q · filed 2024-11-07 |
| 2023-03-31 | $4.52M 10-Q · filed 2024-10-16 |
| 2022-12-31 | $4.49M 10-K · filed 2025-05-08 |
| 2022-09-30 | $4.36M 10-Q · filed 2024-01-03 |
| 2022-06-30 | $4.23M 10-Q · filed 2023-08-14 |
| 2022-03-31 | $4.11M 10-Q · filed 2023-05-22 |
| 2021-12-31 | $4.07M 10-K · filed 2024-07-30 |
| 2021-09-30 | $3.82M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $11.16M 10-Q · filed 2022-08-09 |
| 2021-03-31 | $11.85M 10-Q · filed 2022-05-16 |
| 2020-12-31 | $12.45M 10-K · filed 2023-03-31 |
| 2020-09-30 | $13.67M 10-Q · filed 2021-11-12 |
| 2019-12-31 | $3.83M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |